Recital 27, Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February…

In forcesince 23 Feb 2005

It is necessary that the Authority assess MRL applications and evaluation reports prepared by the Member States, taking into account the full range of toxicological effects such as immunotoxicity, endocrine disruption and developmental toxicity, with a view to determining the associated risks to consumers and, where relevant, to animals.